The abstract is read at the publisher; the summary is JClub's.
Plasma p-tau217/Aβ42 aligns more strongly with Aβ-PET positivity than plasma p-tau217 alone, reducing the intermediate zone and improving concordance in AD cohorts.
- Why it matters: Cross-sectional and longitudinal agreement between plasma p-tau (alone or with Aβ) and Aβ-PET positivity is not fully established, limiting reliable blood-based classification of AD pathology.
- What they did: In 326 ADNI participants and 357 Greater-Bay-Area Healthy Aging Brain Study older adults with Aβ-PET, plasma p-tau181, p-tau217, Aβ42, and Aβ40 were measured on different platforms; longitudinal data were available for 285 ADNI participants.
- The result: Using a two-cutoff approach, p-tau217/Aβ42 reduced the intermediate zone and showed stronger agreement with Aβ-PET positivity; among baseline p-tau217/Aβ42 positive but p-tau217 intermediate individuals, 57.1–83.3% were Aβ-PET positive, and longitudinally 69.7–75.8% of Non-positive to Positive cases were Aβ-PET positive.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.